Skip to main navigation Skip to search Skip to main content

The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid arthritis and ankylosing spondylitis; results from Turkbio Registry.

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S1120-S1120
Number of pages1
JournalArthritis and Rheumatology
Volume66
Publication statusPublished - Oct 2014

Cite this